US BANCORP \DE\ - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,653
-98.5%
437
-95.5%
0.00%
Q2 2023$241,271
+582.6%
9,713
+313.3%
0.00%
Q1 2023$35,344
-86.8%
2,350
-89.6%
0.00%
Q4 2022$268,517
+1313.2%
22,698
+595.0%
0.00%
Q3 2022$19,000
+280.0%
3,266
+153.6%
0.00%
Q2 2022$5,000
-64.3%
1,288
-11.7%
0.00%
Q1 2022$14,000
+100.0%
1,458
+279.7%
0.00%
Q4 2021$7,000
-50.0%
384
-9.0%
0.00%
Q3 2021$14,000
-97.3%
422
-96.9%
0.00%
-100.0%
Q2 2021$525,000
-19.1%
13,552
+0.7%
0.00%0.0%
Q1 2021$649,000
-2.3%
13,464
+5.5%
0.00%0.0%
Q4 2020$664,000
+1444.2%
12,761
+154.2%
0.00%
Q1 2016$43,000
-28.3%
5,0200.0%0.00%
Q4 2015$60,000
+17.6%
5,0200.0%0.00%
Q3 2015$51,000
-39.3%
5,020
-1.2%
0.00%
Q2 2015$84,000
-42.9%
5,080
-46.6%
0.00%
-100.0%
Q1 2015$147,000
-3.3%
9,510
-1.2%
0.00%0.0%
Q4 2014$152,000
+32.2%
9,625
-10.7%
0.00%
Q3 2014$115,000
+13.9%
10,7750.0%0.00%
Q2 2014$101,00010,7750.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders